Rethinking AI Workflows: Guidelines for Scientific Evaluation in Digital Health Companies
ABSTRACT
Artificial intelligence (AI) is revolutionizing digital health, driving innovation in care delivery and operational efficiency. Despite its potential, many AI systems fail to meet real-world expectations due to limited evaluation practices that focus narrowly on short-term metrics like efficiency and technical accuracy. Ignoring factors such as usability, trust, transparency, and adaptability hinders AI adoption, scalability, and long-term impact in health care. This paper emphasizes the importance of embedding scientific evaluation as a core operational layer throughout the AI lifecycle. We outline practical guidelines for digital health companies to improve AI integration and evaluation, informed by over 35 years of experience in science, the digital health industry, and AI development. It describes a multi-step approach, including stakeholder analysis, real-time monitoring, and iterative improvement, that digital health companies can adopt to ensure robust AI integration. Key recommendations include assessing stakeholder needs, designing AI systems that can check its own work, conducting testing to address usability and biases, and ensuring continuous improvement to keep systems user-centered and adaptable. By integrating these guidelines, digital health companies can improve AI reliability, scalability, and trustworthiness, driving better health care delivery and stakeholder alignment.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.